Table 2.

Clinical characteristics of patients at baseline

Characteristic	Hydromethylthionine 8 mg/day (n = 111)	Hydromethylthionine 200 mg/day (n = 109)	Total
Years since bvFTD diagnosis
n	107	106	213
Mean (SD)	1.9 (2.4)	1.9 (2.4)	1.9 (2.4)
Median (range)	0.9 (0.0–14.9)	1.1 (0.0–17.6)	1.1 (0.0–17.6)
MMSE score
Mean (SD)	24.6 (3.1)	24.7 (3.0)	24.6 (3.1)
≤21	28 (25.2%)	26 (23.9%)	54 (24.5%)
22–26	46 (41.4%)	39 (35.8%)	85 (38.6%)
>26	37 (33.3%)	44 (40.4%)	81 (36.8%)
Kipps stage, n (%)
2	38 (34.2%)	42 (38.5%)	80 (36.4%)
3	55 (49.5%)	46 (42.2%)	101 (45.9%)
4	18 (16.2%)	21 (19.3%)	39 (17.7%)